Sep 23 |
DBV Technologies Completes Screening for the VITESSE Phase 3 Clinical Trial
|
Aug 2 |
Information regarding the total number of voting rights and total number of shares of the Company as of July 31, 2024
|
Jul 31 |
DBV Technologies S.A. (DBVT) Q2 2024 Earnings Call Transcript
|
Jul 30 |
DBV Technologies Announces Filing of 2024 Half-Year Report ― Conditions for Accessing or Consulting the Report
|
Jul 30 |
DBV Technologies Provides Updates on the Viaskin Peanut Program in Children and Toddlers and Reports Second Quarter and Half-Year 2024 Financial Results
|
Jul 29 |
DBV Technologies to Report Second Quarter 2024 Financial Results and Business Update on July 30, 2024
|
Jun 5 |
DBV Technologies to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
|
Jun 4 |
Information regarding the total number of voting rights and total number of shares of the Company as of May 31, 2024
|
May 30 |
DBV Technologies to Participate in Upcoming EAACI 2024 Congress
|
May 17 |
DBV Technologies to implement ADS ratio change
|